Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
• Prenetics has completed the majority stake acquisition of ACT Genomics to spearhead its entry into to the US$80+ billion global precision oncology market • FDA market authorization advances personalized cancer care in Asia • Clearance sets the stage for continued R&D investment into early detection / liquid biopsy
Advanced Precision Cancer Medicine Forum will be held on April 17
New medical technologies have been advancing more rapidly than ever, including the application of precision medicine and artificial intelligence in cancer clinical treatment planning and biomarkers discovery. Hosted by Taiwan Oncology Society, ACT Genomics co-organizes the Advanced Precision Cancer Medicine Forum (APCM) and we have invited experts in specific areas to share their first-hand experiences about the latest developments and phenomena in cancer management and valuable insights on the best strategy moving forward.
ACT Genomics & Sanomics cooperate with Novartis to provide free liquid based lung cancer panels for cancer patients
The new corona virus has almost paralyzed the public medical system. Lung cancer patients who originally receive treatments in public hospitals will be affected and some of them have to turn to private doctors for treatments. In order to allow patients to grasp the golden treatment period, ACT Genomics and Novartis will provide free blood based diagnostic testing for 3 months to lung cancer patients seeking medical treatments in the private sector.
Location: Hong Kong
Hope and Rainbows
This year, we invited Abu, an illustrator as well as a cancer fighter, together with the Nurse Educator team in Taiwan, to create a few new paintings which heartily reflect the sensation of fragility and strength, pain and joy as well as inner conflict and relief while fighting against cancer. With these paintings from Abu and the life stories of the patients, we will launch a series of events with the title “Hope and Rainbows” at the end of 2021.